OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Organization: University of Rochester

4 Projects | 3 Researchers | $566,332 Invested

2009

University of Rochester

Rashid Deane, PhD

Early toxicology and ADME studies with our lead RAGE inhibitors

  • Funding Amount: $155,300
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2005

University of Rochester

Berislav Zlokovic, MD, PhD

Blockers of RAGE/amyloid-beta interaction at the blood brain barrier.

  • Funding Amount: $130,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2004

University of Rochester

Berislav Zlokovic, MD, PhD

Blockers of RAGE/Amyloid-Beta Interaction at the Blood Brain Barrier

  • Funding Amount: $165,723
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2002

University of Rochester

Rebekah Loy, PhD

Valproate and Lithium to Inhibit Tau Pathophysiology

  • Funding Amount: $115,309
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed